Patanjali slams USFDA report on differential labelling by Patanjali Ayurveda

CNBC-TV18 2019-07-23

Views 17

Baba Ramdev's Patanjali Ayurveda has slammed the US health regulator USFDA for its report raising concerns about differential labelling by Patanjali Ayurveda. In a report, USFDA had claimed that labels on two Patanjali products sold in India were found to have additional medicinal & dietary claims compared to the products manufactured for exports.

Share This Video


Download

  
Report form